The Environmental Protection Agency (EPA) is facing scrutiny over its chemical approval processes following the appointment of Lynn Dekleva, a former lobbyist for the American Chemistry Council, to a key position overseeing new chemical approvals. Dekleva, who has an extensive background with Dupont and served under the Trump administration, is now spearheading efforts that prioritize the chemical industry’s interests.
Formaldehyde—a chemical widely used in multiple products ranging from furniture to clothing—is notorious for its potential to cause cancer and respiratory issues. The EPA attempted to impose stricter regulations on this hazardous substance starting in 2021, propelling a fierce counter-campaign from the chemicals industry. This was significantly aided by Dekleva during her previous lobbying tenure.
The American Chemistry Council has since intensified its campaign, pushing for the repeal of EPA's risk assessment program for chemicals and impeding regulatory measures targeting formaldehyde. In light of these developments, Dekleva has been urged to recalibrate the EPA’s safety reviews and approval processes, which are critical components of her new responsibilities.
Moreover, Nancy Beck, another former lobbyist from the chemicals council, has also returned to the EPA, reinforcing the lobby's influence within the agency. During a Senate hearing shortly after the Trump administration took office, the president of the council emphasized the importance of chemistry for national health and economic vitality, suggesting that curbing chemical regulations is essential for achieving these goals.
As these dynamics unfold, stakeholders are closely monitoring the implications for public health and environmental safety stemming from the EPA’s regulatory trajectory under Dekleva's stewardship.
